PODD currently trades at 10x revenues compared ... Insulet has enjoyed lofty valuation multiples in the past due to its strong top and bottom-line growth. Our Insulet Valuation Ratios Comparison ...

Insulet (PODD) reported $597.5 million in revenue for ... Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what ...

Insulet (PODD) reported $432.7 million in revenue for ... As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps ...

Insulet (PODD) came out with quarterly earnings of ... Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow PODD in the coming trading sessions, be sure to utilize Zacks.com. Zacks Names ...

Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow PODD in the coming trading sessions, be sure to utilize Zacks.com. Zacks Names ...

I use the relative strength ratio shown in the bottom pane of Chart 1 to analyze the level of outperformance. The relative strength ratio rises when PODD outperforms the SP 500. The relative ...

Insulet (PODD) came out with quarterly earnings of ... In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 26% of the 250 plus Zacks industries.

PODD's full-year Zacks Consensus Estimates are ... This group has a Zacks Industry Rank of 145, putting it in the bottom 43% of all 250+ industries. The Zacks Industry Rank gauges the strength ...